Search filters

List of works by Bruce A C Cree

2014 multiple sclerosis therapeutic update

scientific article

A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

scientific article

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

scientific article published on 28 August 2020

A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis

scientific article published on 10 July 2020

A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility

scientific article published on 25 September 2005

Acute inflammatory myelopathies

scientific article published on January 2014

Acute liver injury in a Glatopa-treated patient with MS.

scientific article published on 5 June 2017

Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies

scientific article published on April 2012

Acute transverse myelitis: is the "idiopathic" form vanishing?

scientific article published on 01 December 2005

An ImmunoChip study of multiple sclerosis risk in African Americans

scientific article published on 28 March 2015

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

scientific article published on 29 September 2013

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

scientific article published in August 2005

Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter

scientific article

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

scientific article published on 12 August 2019

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

scientific article published on 8 June 2015

Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis

scholarly article published 1 March 2019

Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis

scientific article published on 31 May 2016

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

scientific article

Author response: Progressive multifocal leukoencephalopathy after fingolimod treatment

scientific article published on 01 January 2019

B cell exchange across the blood-brain barrier in multiple sclerosis

scientific article

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls

scientific article published on 06 June 2013

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study

scientific article published on 30 January 2018

Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis

scientific article published on 29 December 2020

Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis

scientific article published on 29 March 2017

Challenges and opportunities in designing clinical trials for neuromyelitis optica

scientific article

Characterizing retinal structure injury in African-Americans with multiple sclerosis

scientific article

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions

scientific article

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

scientific article

Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury.

scientific article

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

scientific article

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

scientific article published in April 2018

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.

scientific article published on 28 November 2016

Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm

scientific article published on 01 June 2019

Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?

scientific article published on 16 December 2014

Diagnosing Encephalitis, Not Otherwise Specified-Reply

scientific article

Diagnosis and differential diagnosis of multiple sclerosis

scientific article published on 01 October 2010

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.

scientific article published on 13 April 2016

Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?

scientific article published in March 2014

Disease-modifying therapies alter gut microbial composition in MS

scientific article published on 26 October 2018

Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis.

scientific article published on 21 May 2009

Does race matter for multiple sclerosis?

scientific article published on 20 January 2010

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

scientific article published on 4 February 2014

Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS

scientific article published on 31 July 2020

Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

scientific article published on 24 August 2020

Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data

scientific article

Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge

scientific article

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

scientific article

Genetic risk variants in African Americans with multiple sclerosis

scientific article published on 14 June 2013

Genetics of primary progressive multiple sclerosis

scientific article published on January 2014

Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis

scientific article published on 03 July 2018

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

scientific journal article

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures

scientific article

Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease

scientific article

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.

scientific article published on 11 September 2017

Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens

scientific article

Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis

scientific article published on 01 November 2020

Imaging correlates of visual function in multiple sclerosis

scientific article published on 03 August 2020

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial

scientific article

In vivo evidence of glutamate toxicity in multiple sclerosis

scientific article

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

scientific article published on 05 September 2019

Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis

scientific article published on 01 February 2013

Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis

scientific article published in June 2004

Long-term evolution of multiple sclerosis disability in the treatment era.

scientific article published on 27 July 2016

Low frequency and rare coding variation contributes to multiple sclerosis risk

Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS

scientific article published on 11 September 2019

MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.

scientific article

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study

scientific article

Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis

scientific article

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans

scientific article

Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases

scientific article published on 21 October 2009

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.

scientific article

Microcystic inner nuclear layer abnormalities and neuromyelitis optica

scientific article

Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA

scientific article

Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans

scientific article

Multiple Sclerosis Therapy: Are We Ready for a One-Size-Fits-All Approach?

scientific article published on 01 June 2018

Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria

article

Multiple sclerosis genetics

scientific article published on 01 January 2014

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

scientific article published on 04 August 2016

Natalizumab dosage suspension: are we helping or hurting?

scientific article published on 01 September 2010

Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

scientific article published on 05 November 2020

Neuromyelitis optica following human papillomavirus vaccination

scientific article published on 20 June 2012

Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case report

scientific article

Ocrelizumab and Other CD20(+) B-Cell-Depleting Therapies in Multiple Sclerosis

scientific article

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

scientific article published on 20 December 2016

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

scientific article

Ovarian aging is associated with gray matter volume and disability in women with MS.

scientific article published on 22 December 2017

Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trial.

scientific article

Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis

scientific article

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

scientific article published in April 2018

Precision medicine in chronic disease management: The multiple sclerosis BioScreen

scientific article

Prognostic biomarkers of IFNb therapy in multiple sclerosis patients

scientific article published on 12 November 2014

Progressive multifocal leukoencephalopathy after fingolimod treatment

scientific article published on 18 April 2018

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

scientific article published on May 2009

Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica

scientific article published on October 2010

Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE

scientific article published on 09 November 2014

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

scientific article

Refining the association of MHC with multiple sclerosis in African Americans

scientific article

Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review

scientific article

Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"

scientific article published on 12 July 2019

Response to interferon beta-1a treatment in African American multiple sclerosis patients

scientific article

Retinal INL thickness in multiple sclerosis: a mere marker of neurodegeneration?

scientific article published on 17 October 2020

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients

scientific article published on 15 September 2017

Risk alleles for multiple sclerosis identified by a genomewide study

scientific article (publication date: 30 August 2007)

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

scientific article

Rituximab in neurological disease: principles, evidence and practice

scientific article published on 29 November 2018

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 23 October 2020

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

scientific article published on 03 September 2019

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

scientific article published on 03 September 2019

Silent progression in disease activity-free relapsing multiple sclerosis

scientific article published on 30 March 2019

Simultaneous serum aquaporin-4 antibody and CSF NMDA receptor antibody-positive encephalitis.

scientific article published on 9 April 2015

Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses

scientific article published on 16 December 2020

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

scientific article published on 22 March 2018

Spinal cord gray matter atrophy correlates with multiple sclerosis disability

scientific article published on 21 August 2014

Statistical Considerations for an Adaptive Design for a Serious Rare Disease

scientific article published on 01 May 2016

Steering through complexity: management approaches in multiple sclerosis

scientific article published on 7 April 2016

Switching multiple sclerosis patients with breakthrough disease to second-line therapy

scientific article

Switching to fingolimod in PREFERMS: Effect of treatment history and naïvety on clinical, MRI and treatment satisfaction outcomes✰

scientific article published on 03 July 2020

Telomere Length Is Associated with Disability Progression in Multiple Sclerosis

scientific article published on 02 October 2019

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod

scientific article published on 02 January 2019

The Gut Microbiome in Neuromyelitis Optica

scientific article published on 26 December 2017

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

scholarly article published 13 July 2017

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

scientific article

Transient hyperckemia in the setting of neuromyelitis optica (NMO).

scientific article

Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels

scientific article published on 11 May 2011

Treatment of Multiple Sclerosis: A Review

scientific article published on 16 July 2020

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

scientific article

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression

scientific article published on 21 September 2016

Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study

scientific article published on 11 July 2018

Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis

scientific article

Unusual variants of Alexander's disease

scientific article published on March 2005

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis ⬇️

scientific article published on January 14, 2013

Vitamin D in African Americans with multiple sclerosis.

scientific article

pRNFL as a marker of disability worsening in the medium/long term in patients with MS

scientific article published on 21 December 2018

Paulina is supported by:

About Paulina

Help